Sumanta Pal Selected Research

Melanoma (Melanoma, Malignant)

12/2023	Melanoma and microbiota: Current understanding and future directions.
1/2022	Infectious complications of immune checkpoint inhibitors in solid organ malignancies.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Sumanta Pal Research Topics

Disease

36	Neoplasms (Cancer) 04/2024 - 09/2009
22	Renal Cell Carcinoma (Grawitz Tumor) 01/2023 - 10/2014
13	Prostatic Neoplasms (Prostate Cancer) 10/2023 - 02/2014
10	Carcinoma (Carcinomatosis) 04/2024 - 01/2016
4	Breast Neoplasms (Breast Cancer) 01/2017 - 09/2009
3	Neoplasm Metastasis (Metastasis) 11/2022 - 11/2011
3	Fatigue 01/2020 - 07/2016
3	Nausea 02/2019 - 07/2012
3	Disease Progression 01/2017 - 01/2016
2	Melanoma (Melanoma, Malignant) 12/2023 - 01/2022
2	Kidney Neoplasms (Kidney Cancer) 09/2023 - 12/2021
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2022 - 12/2017
2	Urinary Bladder Neoplasms (Bladder Cancer) 12/2021 - 01/2021
2	COVID-19 01/2021 - 01/2020
2	Hypertension (High Blood Pressure) 01/2020 - 07/2016
2	Adenocarcinoma 10/2019 - 01/2018
2	Hematologic Neoplasms (Hematological Malignancy) 01/2018 - 02/2013
1	Urogenital Neoplasms 12/2023
1	Hemorrhage 01/2023
1	Thrombosis (Thrombus) 01/2023
1	Venous Thromboembolism 01/2023
1	Lymphadenopathy 03/2022
1	Infections 01/2022
1	Renal Insufficiency (Renal Failure) 01/2020
1	Urologic Neoplasms (Urological Cancer) 10/2019
1	Dyspnea (Shortness of Breath) 10/2018

Drug/Important Bio-Agent (IBA)

10	cabozantinibIBA 01/2023 - 07/2016
9	Everolimus FDA Link 01/2023 - 03/2015
8	Immune Checkpoint InhibitorsIBA 12/2023 - 01/2017
7	Biomarkers (Surrogate Marker)IBA 04/2024 - 01/2017
5	DNA (Deoxyribonucleic Acid)IBA 09/2023 - 01/2016
5	PlatinumIBA 01/2023 - 01/2017
4	atezolizumabIBA 03/2022 - 01/2020
4	Cisplatin (Platino)FDA LinkGeneric 06/2021 - 01/2016
3	AndrogensIBA 01/2023 - 01/2020
3	NivolumabIBA 01/2022 - 01/2017
3	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2021 - 02/2019
2	pembrolizumabIBA 01/2023 - 01/2022
2	Hormones (Hormone)IBA 11/2022 - 03/2022
2	enzalutamideIBA 03/2022 - 01/2022
2	abirateroneIBA 03/2022 - 01/2022
2	Tyrosine Kinase InhibitorsIBA 01/2022 - 07/2016
2	IpilimumabIBA 01/2022 - 01/2020
2	COVID-19 VaccinesIBA 05/2021 - 01/2021
2	CytokinesIBA 01/2021 - 01/2017
2	Axitinib (AG 013736)IBA 01/2021 - 03/2015
2	CreatinineIBA 01/2020 - 02/2019
2	Androgen Receptors (Androgen Receptor)IBA 01/2020 - 02/2014
2	Phosphotransferases (Kinase)IBA 06/2019 - 11/2011
2	MTOR InhibitorsIBA 06/2019 - 01/2016
2	Sunitinib (Sutent)FDA Link 02/2019 - 03/2015
2	Sorafenib (BAY 43-9006)FDA Link 02/2019 - 03/2015
2	Estrogen ReceptorsIBA 01/2017 - 09/2009
2	OligonucleotidesIBA 01/2017 - 02/2013
2	Proteins (Proteins, Gene)FDA Link 02/2014 - 02/2013
1	Fibroblast Growth Factor Receptors (Fibroblast Growth Factor Receptor)IBA 04/2024
1	infigratinibIBA 04/2024
1	Mitogen-Activated Protein KinasesIBA 10/2023
1	Serum AlbuminIBA 01/2023
1	AnticoagulantsIBA 01/2023
1	Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)IBA 01/2023
1	relugolixIBA 01/2023
1	lenvatinibIBA 01/2023
1	Gonadotropin-Releasing Hormone (GnRH)FDA Link 11/2022
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2022
1	SteroidsIBA 01/2022
1	Circulating Tumor DNAIBA 12/2021
1	Cell-Free Nucleic AcidsIBA 12/2021
1	Carboplatin (JM8)FDA LinkGeneric 06/2021
1	avelumabIBA 06/2021
1	carotuximabIBA 01/2021
1	sipuleucel-T (APC8015)FDA Link 01/2021
1	EndoglinIBA 01/2021
1	Monoclonal AntibodiesIBA 01/2021
1	VaccinesIBA 01/2021
1	Cancer VaccinesIBA 01/2021
1	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 01/2021
1	FluoridesIBA 01/2020
1	Transforming Growth Factor beta (TGF-beta)IBA 11/2019
1	Type 3 Fibroblast Growth Factor Receptor (Fibroblast Growth Factor Receptor 3)IBA 11/2019
1	cyclopropapyrroloindoleIBA 11/2019
1	Sirolimus (Rapamycin)FDA Link 06/2019
1	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 06/2019
1	trebananibIBA 02/2019
1	Bevacizumab (Avastin)FDA Link 02/2019
1	AngiopoietinsIBA 02/2019
1	pazopanib FDA Link 02/2019

Therapy/Procedure

31	Therapeutics 04/2024 - 09/2009
12	Drug Therapy (Chemotherapy) 01/2023 - 09/2009
7	Immunotherapy 12/2023 - 12/2015
3	Radiotherapy 01/2023 - 11/2022
3	Castration 03/2022 - 01/2021
3	Prostatectomy (Retropubic Prostatectomy) 01/2022 - 01/2018
2	Cystectomy 12/2021 - 01/2016
2	Lymph Node Excision (Lymph Node Dissection) 09/2018 - 01/2018
2	Adjuvant Chemotherapy 07/2012 - 09/2009
1	Nephroureterectomy 04/2024
1	Nephrectomy 01/2023
1	Neoadjuvant Therapy 12/2021
1	Combination Drug Therapy (Combination Chemotherapy) 10/2019